🇺🇸 FDA
Patent

US 8350077

Amides of creatine, method of their preparation, and remedy possessing a neuroprotective activity

granted A61KA61K31/16A61P

Quick answer

US patent 8350077 (Amides of creatine, method of their preparation, and remedy possessing a neuroprotective activity) held by Vertex Closed Joint Stock Company expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Closed Joint Stock Company
Grant date
Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/16, A61P, A61P25/28